skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

3649

Therapeutics and Clinical Risk Management

(846,608) Views

Editor in Chief Professor Garry Walsh

Incidence of spontaneous notifications of adverse reactions with aceclofenac, meloxicam, and rofecoxib during the first year after marketing in the United Kingdom
Anna Raber, Joan Heras, Joan Costa, Josep Fortea, Albert Cobos


Darbepoetin alpha in the treatment of cancer chemotherapy-induced anemia
Alberto Grossi, Francesca Balestri, Simone Santini


Diagnosis and treatment of chronic rhinosinusitis: focus on intranasal Amphotericin B
Eugene B Kern, David Sherris, Angelos M Stergiou, Laura M Katz, Lisa C Rosenblatt, Jens Ponikau


Montelukast in the management of allergic rhinitis
Jaime A Lagos, Gailen D Marshall


Natalizumab: A new treatment for relapsing remitting multiple sclerosis
Michael Hutchinson

Editorial || FREE PAPER ||
Garry M Walsh


Skin and skin structure infections: treatment with newer generation fluoroquinolones
Philip Giordano, Kurt Weber, Gail Gesin, Jason Kubert


Dapoxetine, a novel selective serotonin transport inhibitor for the treatment of premature ejaculation
Muammer Kendirci, Emad Salem, Wayne JG Hellstrom


Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST)
Christophe Le Tourneau, Eric Raymond, Sandrine Faivre


An overview of the clinical use of ondansetron in preschool age children
Ira Todd Cohen


Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors
Jean-Pierre Armand, Vincent Ribrag, Jean-Luc Harrousseau, Lauren Abrey

Exjade® (deferasirox, ICL670) in the treatment of chronic iron overload associated with blood transfusion
Maria Domenica Cappellini

The safety of etanercept for the treatment of plaque psoriasis
Kim A Papp

Long-term management of gastroesophageal reflux disease with pantoprazole
Theo Scholten


A smarter way to manage asthma with a combination of a long-acting β2-agonist and inhaled corticosteroid
Olof Selroos

Infliximab in the treatment of Crohn’s disease
Gilberto Poggioli, Silvio Laureti, Massimo Campieri, Filippo Pierangeli, Paolo Gionchetti, et al

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University

  • Journal Indexing

    See where all the Dove Press journals are indexed